Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Non-Current Debt (2016 - 2020)

Historic Non-Current Debt for Cardiff Oncology (CRDF) over the last 6 years, with Q2 2020 value amounting to $234270.0.

  • Cardiff Oncology's Non-Current Debt changed N/A to $234270.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $234270.0, marking a year-over-year change of. This contributed to the annual value of $14.2 million for FY2016, which is 2605.48% up from last year.
  • As of Q2 2020, Cardiff Oncology's Non-Current Debt stood at $234270.0.
  • Over the past 5 years, Cardiff Oncology's Non-Current Debt peaked at $15.6 million during Q3 2016, and registered a low of $234270.0 during Q2 2020.
  • Its 3-year average for Non-Current Debt is $10.4 million, with a median of $11.5 million in 2016.
  • Within the past 5 years, the most significant YoY rise in Cardiff Oncology's Non-Current Debt was 3538.66% (2016), while the steepest drop was 2988.96% (2016).
  • Over the past 3 years, Cardiff Oncology's Non-Current Debt (Quarter) stood at $14.2 million in 2016, then dropped by 10.42% to $12.7 million in 2017, then crashed by 98.16% to $234270.0 in 2020.
  • Its Non-Current Debt stands at $234270.0 for Q2 2020, versus $12.7 million for Q1 2017 and $14.2 million for Q4 2016.